表 3. ROC analysis of interferon efficacy according to the serum HBsAg and HBV pgRNA levels in different populations.
不同人群血清HBsAg和HBV pgRNA水平判断干扰素疗效的ROC分析
| Group | Index | AUC | 95% CI | Optimal cut-off value | Sensitivity/% | Specificity/% | P |
| AUC: area under thecurve; CI: confidence interval. | |||||||
| Previously treated | HBsAg | 0.80 | 0.7423-0.8615 | 244.60 IU/mL | 77.78 | 72.39 | <0.0001 |
| HBV pgRNA | 0.58 | 0.4586-0.7024 | 3955.00 copies/mL | 77.78 | 42.13 | 0.2606 | |
| Initial treatment | HBsAg | 0.74 | 0.6283-0.8604 | 934.40 IU/mL | 100.00 | 50.85 | 0.0079 |
| HBV pgRNA | 0.96 | 0.9042-1.0000 | 1340.00 copies/mL | 94.74 | 88.89 | <0.0001 | |